iGMDRD25
Canonical SMILES: CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI: InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)
InChI Key: YOSHYTLCDANDAN-UHFFFAOYSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard Name138402-11-6 CHEMBLCHEMBL1513 Pubchem CID3749 KEGG Drug IDD00523 DRUGBANK IDDB01029 Drug StatusAlone Drug targets (TTD)DAP000364 Drug TypeSmall Molecule |
Drug Class:
Agents Acting on the Renin-Angiotensin SystemAngiotensin 2 Receptor BlockerAngiotensin IIAngiotensin II Antagonists and Calcium Channel BlockersAngiotensin II Antagonists and DiureticsAngiotensin II Antagonists, PlainAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor AntagonistsAntihypertensive AgentsAzolesBenzene DerivativesCardiovascular AgentsCardiovascular SystemCytochrome P-450 CYP2C8 InhibitorsCytochrome P-450 CYP2C8 Inhibitors (moderate)Cytochrome P-450 CYP2C9 SubstratesCytochrome P-450 Enzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHypotensive AgentsDrug Pathways:
Neuroactive ligand-receptor interactionAdrenergic signaling in cardiomyocytesVascular smooth muscle contractionRenin-angiotensin systemDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in 138402-11-6
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |